Dr Michael Badminton

2014

• Schulenburg-Brand, D., Katugampola, R., Anstey, A. and Badminton, M. 2014. The cutaneous porphyrias. Dermatologic Clinics 32(3), pp. 369-384. (10.1016/j.det.2014.03.001)

2013

• Whatley, S. and Badminton, M. 2013. Role of genetic testing in the management of patients with inherited porphyria and their families. Annals of Clinical Biochemistry 50(3), pp. 204-216. (10.1177/0004563212473278)

2012

• Katugampola, R. P. et al. 2012. Congenital erythropoietic porphyria: A single-observer clinical study of 29 cases. British Journal Of Dermatology 167(4), pp. 901-913. (10.1111/j.1365-2133.2012.11160.x)
• Katugampola, R. P. et al. 2012. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. British Journal Of Dermatology 167(4), pp. 888-900. (10.1111/j.1365-2133.2012.11154.x)
• Khan, M., Badminton, M. N., Shortland, G. J., Thomas, D. M. and Moat, S. J. 2012. Neurodegeneration in a patient with methylmalonic aciduria following combined liver and kidney transplantations: the mechanism of neurotoxicity? [Abstract]. Journal of Inherited Metabolic Disease 35(s1), pp. s61. (10.1007/s10545-012-9512-z)
• Stein, P. E., Badminton, M. N., Barth, J. H., Rees, D. C., Sarkany, R., Stewart, M. F. and Cox, T. M. 2012. Acute intermittent porphyria: fatal complications of treatment. Clinical Medicine 12(3), pp. 293-294.
• Dowman, J. K., Gunson, B. K., Mirza, D. F., Bramhall, S. R., Badminton, M. N. and Newsome, P. N. 2012. Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis. Liver Transplantation 18(2), pp. 195-200. (10.1002/lt.22345)
• Badminton, M. N. 2012. Commentary: Retracing an old journey in variegate porphyria. British Journal Of Dermatology 166(2), pp. 237. (10.1111/j.1365-2133.2011.10739.x)

2011

• Aarsand, A. K. et al. 2011. European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clinical Chemistry 57(11), pp. 1514-1523. (10.1373/clinchem.2011.170357)
• Ali, F., Ingram, J. R., Whatley, S., Badminton, M. N. and Anstey, A. V. 2011. X-linked dominant protoporphyria due to a novel mutation in ALAS2: a case report [Abstract]. British Journal of Dermatology 164(5), pp. 1167-1167. (10.1111/j.1365-2133.2011.10357.x)
• Ingram, J. R., Cole, D. S., Czajkowski, M., Anstey, A. V. and Badminton, M. N. 2011. An unusual complication of jaundice [Abstract]. British Journal of Dermatology 164(5), pp. 1168-1168. (10.1111/j.1365-2133.2011.10357.x)
• Dowman, J. K., Gunson, B. K., Mirza, D. F., Badminton, M. N. and Newsome, P. N. 2011. UK experience of liver transplantation for erythropoietic protoporphyria. Journal of Inherited Metabolic Disease 34(2), pp. 539-545. (10.1007/s10545-010-9272-6)
• Dowman, J. K., Gunson, B. K., Bramhall, S., Badminton, M. N. and Newsome, P. N. 2011. Liver transplantation from donors with acute intermittent porphyria [Letter]. Annals of International Medicine 154(8), pp. 571-572.
• Badminton, M. N. and Elder, G. H. 2011. Porphyrias. In: Wass, J. A. H. and Stewart, P. M. eds. Oxford Textbook of Endocrinology and Diabetes. 2nd ed.. Oxford: Oxford University Press, pp. 1694-1700.
• Sarkany, R. P. E. et al. 2011. Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria [Letter]. Journal of Investigative Dermatology 131(5), pp. 1172-1175. (10.1038/jid.2011.5)

2010

• Whatley, S. D., Mason, N. G., Holme, S. A., Anstey, A. V., Elder, G. H. and Badminton, M. N. 2010. Molecular epidemiology of erythropoietic protoporphyria in the U.K.. British Journal of Dermatology 162(3), pp. 642-646. (10.1111/j.1365-2133.2010.09631.x)

2009

• Whatley, S. D., Mason, N. G., Woolf, J., Newcombe, R. G., Elder, G. H. and Badminton, M. N. 2009. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clinical Chemistry 55(7), pp. 1406-1414. (10.1373/clinchem.2008.122564)
• Holme, S. A. et al. 2009. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance. Journal of Investigative Dermatology 129(3), pp. 599-605. (10.1038/jid.2008.272)
• Badminton, M. N. and Elder, G. H. 2009. Inherited disorders of haem synthesis: the human porphyrias. In: Warren, M. J. and Smith, A. G. eds. Tetrapyrroles: birth, life, and death. Molecular biology intelligence unit Austin, Texas: Landes Bioscience, pp. 89-100.
• Holme, S., Anstey, A. V., Whatley, S. D., Elder, G. H. and Badminton, M. N. 2009. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma - reply [Letter]. British Journal of Dermatology 161(4), pp. 966-967. (10.1111/j.1365-2133.2009.09407.x)

2008

• Whatley, S. D. et al. 2008. C-Terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. American Journal of Human Genetics 83(3), pp. 408-414. (10.1016/j.ajhg.2008.08.003)
• Badminton, M. N. and Elder, G. H. 2008. The porphyrias: inherited disorders of haem synthesis. In: Marshall, W. J. and Bangert, S. K. eds. Clinical biochemistry: metabolic and clinical aspects. 2nd ed. Edinburgh: Churchill Livingstone Elsevier, pp. 558-577.
• Holme, S. A., Anstey, A. V., Badminton, M. N. and Elder, G. H. 2008. Serum 25-hydroxyvitamin D in erythropoietic protoporphyria. British Journal of Dermatology 159(1), pp. 211-213. (10.1111/j.1365-2133.2008.08616.x)
• Thomas, C. L., Badminton, M. N., Rendall, J. R. S. and Anstey, A. V. 2008. Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda. Clinical and Experimental Dermatology 33(4), pp. 422-424. (10.1111/j.1365-2230.2007.02579.x)

2007

• Holme, S. A., Worwood, M., Anstey, A. V., Elder, G. H. and Badminton, M. N. 2007. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 110(12), pp. 4108-4110. (10.1182/blood-2007-04-088120)
• Whatley, S. D., Mason, N. G., Holme, S. A., Anstey, A. V., Elder, G. H. and Badminton, M. N. 2007. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria. Journal of Investigative Dermatology Advanc, pp. 1-5. (10.1038/sj.jid.5700924)
• Hallai, N., Anstey, A. V., Mendelsohn, S., Williams, J., Evans-Jones, G., Malick, S. and Badminton, M. N. 2007. Pregnancy in a Patient with Congenital Erythropoietic Porphyria [Letter]. New England Journal of Medicine 357(6), pp. 622-623. (10.1056/NEJMc070009)
• Holme, S. A., Thomas, C. L., Whatley, S. D., Bentley, D. P., Anstey, A. V. and Badminton, M. N. 2007. Symptomatic response of erythropoietic protoporphyria to iron supplementation [Letter]. Journal of the American Academy of Dermatology 56(6), pp. 1070-1072. (10.1016/j.jaad.2006.11.030)
• Seth, A. K., Badminton, M. N., Mirza, D., Russell, S. and Elias, E. 2007. Liver transplantation for porphyria: who, when, and how?. Liver Transplantation 13(9), pp. 1219-1227. (10.1002/lt.21261)
• Taibjee, S. M. et al. 2007. Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: a treatment dilemma. British Journal of Dermatology 156(3), pp. 567-571. (10.1111/j.1365-2133.2006.07699.x)

2006

• Goodwin, R. G. et al. 2006. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelastase gene in hematopoietic cells. Blood 107(1), pp. 60-62. (10.1182/blood-2004-12-4939)
• Holme, S. A., Anstey, A. V., Finlay, A. Y., Elder, G. H. and Badminton, M. N. 2006. Erythropoietic protoporphyria in the United Kingdom: clinical features and effect on quality of life. British Journal of Dermatology 155(3), pp. 574-81. (10.1111/j.1365-2133.2006.07472.x)
• Holme, S. A., Anstey, A. V., Finlay, A. Y., Elder, G. H. and Badminton, M. N. 2006. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. British Journal of Dermatology 155(3), pp. 574-581. (10.1111/j.1365-2133.2006.07472.x)
• Bharati, A., Badminton, M. N., Whatley, S. D., O'Brien, D. V. and Bell, H. K. 2006. Late-onset erythropoietic protoporphyria in association with haematological malignancy. Clinical and Experimental Dermatology 31(5), pp. 668-670. (10.1111/j.1365-2230.2006.02179.x)
• Badminton, M. N. and Deybach, J. C. 2006. Treatment of an acute attack of porphyria during pregnancy [Letter]. European Journal of Neurology 13(6), pp. 668-669. (10.1111/j.1468-1331.2006.01238.x)
• Wood, L. H., Whatley, S. D., McKenna, K. and Badminton, M. N. 2006. Exonic deletions as a cause of erythropoietic protoporphyria. Annals of Clinical Biochemistry 43(3), pp. 229-232. (10.1258/000456306776865160)
• Goodwin, R. G. et al. 2006. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells. Blood 107(1), pp. 60-62. (10.1182/blood-2004-12-4939)

2004

• Syed, A. A., Wheatley, H. A., Badminton, M. N. and McDowell, I. F. 2004. Urinary catecholamines and metabolites in the immediate postoperative period following major surgery. Journal of Clinical Pathology 57(5), pp. 548-550. (10.1136/jcp.2003.013201)
• Soonawalla, Z. F., Orug, T., Badminton, M. N., Elder, G. H., Rhodes, J. M., Bramhall, S. R. and Elias, E. 2004. Liver transplantation as a cure for acute intermittent porphyria. Lancet 363(9410), pp. 705-6. (10.1016/S0140-6736(04)15646-8)
• Whatley, S. D. et al. 2004. Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. Journal of Medical Genetics 41(8), article number: e105. (10.1136/jmg.2003.016121)
• Syed, A. A., Wheatley, H. A. and Badminton, M. N. 2004. Urinary catecholamines and metabolites in the immediate postoperative period following major surgery - Correction. Journal of Clinical Pathology 57(7), pp. 784. (10.1136/jcp.2003.013201corr1)

2002

• Badminton, M. N. and Elder, G. H. 2002. Management of acute and cutaneous porphyrias. International Journal of Clinical Practice 56(4), pp. 272-278.

2001

• Hsu, S. et al. 2001. Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway. The Journal of Immunology 166(10), pp. 6126-6133.

1998

• Sala-Newby, G. B., Taylor, K. M., Badminton, M. N., Rembold, C. M. and Campbell, A. K. 1998. Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement. Immunology 93(4), pp. 601-609. (10.1046/j.1365-2567.1998.00004.x)
• Badminton, M. N., Kendall, J. M., Rembold, C. M. and Campbell, A. K. 1998. Current evidence suggests independent regulation of nuclear calcium. Cell Calcium 23(2-3), pp. 79-86. (10.1016/S0143-4160(98)90105-1)
• Kendall, J. M. and Badminton, M. N. 1998. Aequorea victoria bioluminescence moves into an exciting new era. Trends in Biotechnology 16(5), pp. 216-224. (10.1016/S0167-7799(98)01184-6)

1996

• Badminton, M. N., Campbell, A. K. and Rembold, C. M. 1996. Differential regulation of nuclear and cytosolic Ca2+ in HeLa cells. Journal of Biological Chemistry 271(49), pp. 31210-31214. (10.1074/jbc.271.49.31210)
• Kendall, J. M., Badminton, M. N., Sala-Newby, G. B., Campbell, A. K. and Rembold, C. M. 1996. Recombinant apoaequorin acting as a pseudo-luciferase reports micromolar changes in the endoplasmic reticulum free Ca2+ of intact cells. Biochemical Journal 318, pp. 383-387.
• Kendall, J. M., Badminton, M. N., Sala-Newby, G. B., Wilkinson, G. W. G. and Campbell, A. K. 1996. Agonist-stimulated free calcium in subcellular compartments - Delivery of recombinant aequorin to organelles using a replication deficient adenovirus vector. Cell Calcium 19(2), pp. 133-142. (10.1016/S0143-4160(96)90082-2)

1995

• Badminton, M. N., Sala-Newby, G. B., Kendall, J. M. and Campbell, A. K. 1995. Differences in stability of recombinant apoaequorin within subcellular compartments. Biochemical and Biophysical Research Communications 217(3), pp. 950-957. (10.1006/bbrc.1995.2862)
• Campbell, A. K., Badminton, M. N., Kendall, J. M., Sala-Newby, G. B. and Wilkinson, G. W. G. 1995. Free Ca2+ in cellular compartments studied using targeted aequorin [Abstract]. Journal of Physiology 487(P), pp. 7S.
• Kendall, J. M., Badminton, M. N., Sala-Newby, G. B., Wilkinson, G. W. G., Dormer, R. L. and Campbell, A. K. 1995. Changes in free Ca2+ in organelles monitored by targeted recombinant aequorin; use of replication-deficient adenovirus vectors [Communication]. Journal of Physiology 487, pp. 19P.
• Badminton, M. N., Kendall, J. M., Sala-Newby, G. B. and Campbell, A. K. 1995. Nucleoplasmin-targeted aequorin provides evidence for a nuclear calcium barrier. Experimental Cell Research 216(1), pp. 236-243. (10.1006/excr.1995.1030)

1994

• Kendall, J. M., Badminton, M. N., Dormer, R. L. and Campbell, A. K. 1994. Changes in free calcium in the endoplasmic reticulum of living cells detected using targeted aequorin. Analytical Biochemistry 221(1), pp. 173-181. (10.1006/abio.1994.1394)

1993

• Crane, T., Badminton, M. N., Dawson, C. M. and Rainbow, S. J. 1993. Mefenamic acid prevents assessment of drug abuse with EMIT assays [Letter]. Clinical Chemistry 39(3), pp. 549.

1992

• Badminton, M. N., Dawson, C. M., Rainbow, S. J., Francis, C. M. and Tickner, T. R. 1992. Evaluation of a new rapid immunometric method for the measurement of the MB isoenzyme of creatine kinase in serum. Annals of Clinical Biochemistry 29(5), pp. 563-564.

1991

• Badminton, M. N., Dawson, C. M., Rainbow, S. J. and Tickner, T. 1991. Use of a non-extraction HPLC technique for measuring angiotensin-converting enzyme under optimum conditions. Annals of Clinical Biochemistry 28(4), pp. 396-400.

1983

• de L Milton, R. C., King, J. A., Badminton, M. N., Tobler, C. J., Lindsey, G. G., Fridkin, M. and Millar, R. P. 1983. Comparative structure-activity studies on mammalian [Arg8] LH-RH and chicken [Gln8] LH-RH by fluorimetric titration. Biochemical and Biophysical Research Communications 111(3), pp. 1082-1088. (10.1016/0006-291X(83)91410-9)